Table 4.
Patient-reported outcome. Scores in bold were statistically significant better for barrier film in the individual trials (p < 0.05).
| authors | assessment tool | barrier filmb |
controlb |
||||||
|---|---|---|---|---|---|---|---|---|---|
| pain | itching | burning | limitation | pain | itching | burning | limitation | ||
| Herst et al. | RISRAS | N/Ac | N/Ac | ||||||
| Schmeel et al. (a) | RISRAS | 0.44 | 0.32 | 0.44 | 0.24 | 0.83 | 1.00 | 0.80 | 0.48 |
| Møller et al. | PROMa | 0.59 | 0.70 | 0.45 | 0.19 | 1.08 | 1.01 | 0.73 | 0.25 |
| Schmeel et al. (b) | RISRAS | 0.18 | 0.22 | 0.12 | 0.07 | 0.72 | 0.95 | 0.74 | 0.24 |
| Behroozian et al. | RISRAS, SSA | 0.80 | 0.80 | 0.50 | 0.30 | 1.10 | 1.00 | 0.70 | 0.40 |
| total | 0.66° | 0.67° | 0.44° | 0.25° | 1.02 | 1.00 | 0.72 | 0.37 | |
RISRAS = Radiation-Induced Skin Reaction Assessment Scale; PROM = patient-reported outcome measures; SSA = Skin Symptom Assessment; N/A = not available.
° p < 0.05.
Based on RISRAS.
Mean maximum scores.
Herst et al. only reported the combined (clinician + patient) RISRAS scores.